• #1161081
  • 222
  • Seqirus USA Inc #70461012003

FLUAD™ 2020 - 2021 Flu Vaccine, Adjuvanted 45 mcg / 0.5 mL Indicated For People 65 Years of Age and Above Prefilled Syringe 0.5 mL

FLUAD 2020, QUAD SYR 0.5ML 65+YEAR ADJ (10DOSE/BX)

Features
  • Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUAD is approved for use in persons 65 years of age and older
  • Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2020 - 2021 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus)
  • More …
  Log In to Order
or

Product Specifications


McKesson #1161081
Manufacturer #70461012003
BrandFLUAD™ 2020 - 2021
ManufacturerSeqirus USA Inc
Country of OriginUnited States
ApplicationFlu Vaccine, Adjuvanted
Container TypePrefilled Syringe
Dosage FormInjection
NDC Number70461-0120-03
Storage RequirementsRequires Refrigeration
Strength45 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201608
UserIndicated For People 65 Years of Age and Above
Volume0.5 mL
Features
  • Fluad is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine
  • FLUAD is approved for use in persons 65 years of age and older
  • Each 0.5 mL dose contains at least 15 mcg of hemagglutinin (HA) from each of the following three influenza strains recommended for the 2020 - 2021 influenza season; A/Brisbane/02/2018 IVR-190 (an A/Brisbane/02/2018 (H1N1)pdm09-like virus), A/Kansas/14/2017 X-327 (an A/Kansas/14/2017 (H3N2)-like virus), B/Maryland/15/2016 (a B/Colorado/06/2017-like virus)
  • FLUAD also contains MF59C.1 adjuvant (MF59®), a squalene based oil-in-water emulsion